- Home
- ORN vs RCKT Comparison
ORN vs RCKT Comparison
Compare ORN & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORN
- RCKT
- Stock Information
- Founded
- ORN 1994
- RCKT 1999
- Country
- ORN United States
- RCKT United States
- Employees
- ORN N/A
- RCKT N/A
- Industry
- ORN Military/Government/Technical
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- ORN Industrials
- RCKT Health Care
- Exchange
- ORN Nasdaq
- RCKT Nasdaq
- Market Cap
- ORN 330.6M
- RCKT 328.6M
- IPO Year
- ORN 2007
- RCKT N/A
- Fundamental
- Price
- ORN $9.02
- RCKT $3.85
- Analyst Decision
- ORN Strong Buy
- RCKT Buy
- Analyst Count
- ORN 2
- RCKT 13
- Target Price
- ORN $11.25
- RCKT $12.88
- AVG Volume (30 Days)
- ORN 263.4K
- RCKT 3.1M
- Earning Date
- ORN 10-28-2025
- RCKT 11-03-2025
- Dividend Yield
- ORN N/A
- RCKT N/A
- EPS Growth
- ORN N/A
- RCKT N/A
- EPS
- ORN 0.24
- RCKT N/A
- Revenue
- ORN $835,917,000.00
- RCKT N/A
- Revenue This Year
- ORN $4.75
- RCKT N/A
- Revenue Next Year
- ORN $6.76
- RCKT $3,582.16
- P/E Ratio
- ORN $31.61
- RCKT N/A
- Revenue Growth
- ORN 7.02
- RCKT N/A
- 52 Week Low
- ORN $4.64
- RCKT $2.19
- 52 Week High
- ORN $9.95
- RCKT $18.17
- Technical
- Relative Strength Index (RSI)
- ORN 61.62
- RCKT 55.13
- Support Level
- ORN $8.28
- RCKT $3.67
- Resistance Level
- ORN $9.05
- RCKT $4.06
- Average True Range (ATR)
- ORN 0.44
- RCKT 0.26
- MACD
- ORN 0.02
- RCKT -0.00
- Stochastic Oscillator
- ORN 91.86
- RCKT 39.57
About ORN Orion Group Holdings Inc. Common
Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.